The peripheral blood CD4/CD8 ratio may serve as a marker of chronic immune activation, and may be clinically useful in identifying HIV+ individuals at risk for chronic lung disease related to increased inflammation, particularly emphysema. The gene discussed is CD8A; the disease is pulmonary emphysema.